Are serum leptin levels a prognostic factor in advanced lung cancer?

Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar

Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Session: Lung cancer: prognostic factors and features of oncogene-driven tumours
Session type: Thematic Poster Session
Number: 4245

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar. Are serum leptin levels a prognostic factor in advanced lung cancer?. Eur Respir J 2015; 46: Suppl. 59, 4245

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Serum osteopontin as a prognostic marker in patients with lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


The prognostic value of D-dimer in lung carcinoma
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Serum level of interleukin-6 as a prognostic factor in advanced nonsmall-cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003

Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors?
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Correlation between the simultaneus expression of HER2 and PTEN and the risk of development of metastasis in NSCLC
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

The impact of lung cancer resection surgery on fibrinogen and C-reactive protein and their relationship with patients outcomes: A prospective follow up study
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology
Source: Eur Respir J 2013; 41: 410-416
Year: 2013



Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016